Capital International Investors Invests $3.48 Billion in Marsh & McLennan Companies, Inc. $MRSH

Capital International Investors purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the 4th quarter, HoldingsChannel reports. The fund purchased 18,766,815 shares of the financial services provider’s stock, valued at approximately $3,482,557,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of MRSH. Brighton Jones LLC increased its position in shares of Marsh & McLennan Companies by 51.2% during the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock valued at $1,856,000 after acquiring an additional 2,960 shares during the last quarter. Bison Wealth LLC increased its position in shares of Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock valued at $651,000 after acquiring an additional 869 shares during the last quarter. Glenview Trust co increased its position in shares of Marsh & McLennan Companies by 10.8% during the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after acquiring an additional 379 shares during the last quarter. Osterweis Capital Management Inc. increased its position in shares of Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock valued at $203,000 after acquiring an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC acquired a new position in shares of Marsh & McLennan Companies in the second quarter valued at approximately $1,307,000. 87.99% of the stock is owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Stock Up 2.5%

Shares of Marsh & McLennan Companies stock opened at $165.37 on Friday. The firm has a market capitalization of $79.89 billion, a PE ratio of 20.67, a price-to-earnings-growth ratio of 2.41 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $231.36. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. Equities analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Insider Transactions at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on MRSH. Raymond James Financial upgraded shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective for the company in a report on Tuesday, February 17th. Wells Fargo & Company dropped their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a report on Thursday, April 9th. Keefe, Bruyette & Woods lifted their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a report on Friday, April 17th. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, May 6th. Finally, Barclays decreased their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $203.56.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.